A Groupwide Randomized Phase II Window Study of Two Different Schedules of Irinotecan in Combination With Vincristine And Pilot Assessment of Safety and Efficacy of Tirapazamine Combined With Multiagent Chemotherapy for First Relapse or Progressive Disease in Rhabdomyosarcoma and Related Tumors

Trial Profile

A Groupwide Randomized Phase II Window Study of Two Different Schedules of Irinotecan in Combination With Vincristine And Pilot Assessment of Safety and Efficacy of Tirapazamine Combined With Multiagent Chemotherapy for First Relapse or Progressive Disease in Rhabdomyosarcoma and Related Tumors

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jan 2013

At a glance

  • Drugs Irinotecan (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Ifosfamide; Tirapazamine; Vincristine
  • Indications Rhabdomyosarcoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Jan 2011 Primary endpoint 'Objective-clinical-response-rate' has not been met
    • 16 Dec 2010 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
    • 16 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top